Transcriptionally deficient prodynorphyn promoter alleles are associated with temporal lobe epilepsy;Asociación entre alelos transcripcionalmente deficientes del gen de la prodinorfina y el desarrollo de epilepsia del lóbulo temporal

Revista Neurologica Argentina

Volumn 32, Issue 1, 2007, Pages 40-46

  Kauffman, Marcelo Andrés ^a,b   Consalvo, Damián ^a   Gonzalez Moron, Dolores ^b   Kochen, Silvia ^a  

^a CONICET ^*

^b HOSPITAL RAMOS MEJÍA   (Argentina)

Author keywords

Epilepsy; Genetics; Hippocampal sclerosis; Meta analysis; Polymorphism; Prodynorphin

Indexed keywords

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TEMPORAL LOBE EPILEPSY;

EID: 46349091821     PISSN: 03250938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Berkovic SF, Jackson GD. The hippocampal sclerosis whodunit: enter the genes. Ann Neurol 2000; 47 (5): 557-8.
2. Meyer A, Falconer MA, Beck E. Pathological findings in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1954; 17 (4): 276-85.
3. Falconer MA, Meyer A, Hill D, Mitchell W, Pond DA. Treatment of temporal-lobe epilepsy by temporal lobectomy; a survey of findings and results. Lancet 1955; 268 (6869): 827-35.
4. Falconer MA, Serafetinides EA, Corsellis JA. Etiology and Pathogenesis of Temporal Lobe Epilepsy. Arch Neurol 1964; 10: 233-48.
5. Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002; 30 (3): 335-41.
6. Briellmann RS, Torn-Broers Y, Jackson GD, Berkovic SF. Seizures in family members of patients with hippocampal sclerosis. Neurology 2001; 57 (10): 1800-4.
7. Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003; 44 (6): 796-9.
8. Walz R, Castro RM, Velasco TR, et al. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003; 61 (9): 1204-10.
9. Stogmann E, Zimprich A, Baumgartner C, Aull-Watschinger S, Hollt V, Zimprich F. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002; 51 (2): 260-3.
10. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55 (3): 435-7.
11. Buono RJ, Lohoff FW, Sander T, et al. Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res 2004; 58 (2-3): 175-83.
12. Kauffman M, Consalvo D, Levy E, Mordoh J, Kochen S. El Polimorfismo G1465A Del Gen GABBR1 es un Marcador de Riesgo para el desarrollo de Epilepsia Mesial Temporal Con Esclerosis Del Hipocampo. Rev Neurol Arg 2006; 31 (1): 25-31.
13. Solbrig MV, Koob GF. Epilepsy, CNS viral injury and dynorphin. Trends Pharmacol Sci 2004; 25 (2): 98-104.
14. Merg F, Filliol D, Usynin I, et al. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor. J Neurochem 2006; 97 (1): 292-301.
15. Kiraly KP, Riba P, D'Addario C, et al. Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime. Brain Res Bull 2006; 70 (3): 233-9.
16. Solbrig MV, Adrian R, Chang DY, Perng GC. Viral risk factor for seizures: Pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model. Neurobiol Dis 2006.
17. Nadler JV. The recurrent mossy fiber pathway of the epileptic brain. Neurochem Res 2003; 28 (11): 1649-58.
18. Zimprich A, Kraus J, Woltje M, Mayer P, Rauch E, Hollt V. An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. J Neurochem 2000; 74 (2): 472-7.
19. Ogita K, Kitayama T, Okuda H, Yoneda Y. Effects of glutathione depletion by 2-cyclohexen-1-one on excitatory amino acids-induced enhancement of activator protein-1 DNA binding in murine hippocampus. J Neurochem 2001; 76 (6): 1905-15.
20. Alakurtti K, Virtaneva K, Joensuu T, Palvimo JJ, Lehesjoki AE. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene 2000; 242 (1-2): 65-73.
21. Tilgen N, Rebstock J, Horvath S, Propping P, Elger CE, Heils A. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Ann Neurol 2003; 53 (2): 280-1; author reply 1-2.
22. Gambardella A, Manna I, Labate A, et al. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Epilepsia 2003; 44 (9): 1255-6.
23. Cavalleri GL, Lynch JM, Depondt C, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain 2005; 128 (Pt 8): 1832-40.
24. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361(9360): 865-72.
25. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005; 366 (9493): 1315-23.
26. Tan NC, Mulley JC, Scheffer IE. Genetic dissection of the common epilepsies. Curr Opin Neurol 2006; 19 (2): 157-63.
27. Munafo MR. Candidate gene studies in the 21st century: meta-analysis, mediation, moderation. Genes Brain Behav 2006; 5 Suppl 1: 3-8.
28. Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 2004; 19 (3): 419-28.
29. Bradburn M. metan - an alternative meta-analysis command. Stata Technical Bulletin 1998; 44: 4-15.
30. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 2005; 34 (6): 1319-28.
31. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5 (2): 89-100.
32. Lin BK, Clyne M, Walsh M, et al. Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol 2006; 164 (1): 1-4.
33. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001; 20 (23): 3625-33.
34. Malow BA. Sleep and epilepsy. Neurol Clin 2005; 23 (4): 1127-47.